SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-009794
Filing Date
2022-02-28
Accepted
2022-02-28 17:00:30
Documents
12
Period of Report
2022-02-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea156262-8k_oramed.htm   iXBRL 8-K 34173
  Complete submission text file 0001213900-22-009794.txt   208164

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE ormp-20220228_lab.xml EX-101.LAB 34476
3 XBRL PRESENTATION FILE ormp-20220228_pre.xml EX-101.PRE 22591
4 XBRL SCHEMA FILE ormp-20220228.xsd EX-101.SCH 3027
6 EXTRACTED XBRL INSTANCE DOCUMENT ea156262-8k_oramed_htm.xml XML 3727
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35813 | Film No.: 22690926
SIC: 2834 Pharmaceutical Preparations